Tuning composition and architecture of biomimetic scaffolds for enhanced matrix synthesis by murine cardiomyocytes

Journal of Biomedical Materials Research - Part A

Volumn 103, Issue 2, 2015, Pages 693-708

  Gishto, Arsela ^a   Farrell, Kurt ^a   Kothapalli, Chandrasekhar R ^a  

^a Cleveland State University   (United States)

Author keywords

cardiomyocytes; elastin; hydrogels; matrix synthesis; nanofibers

Indexed keywords

BIOMIMETIC PROCESSES; BIOMIMETICS; BIOSYNTHESIS; CARDIOLOGY; COLLAGEN; DEPOSITION; ELASTIN; ENZYME INHIBITION; HEART; HYDROGELS; IMAGING TECHNIQUES; MAMMALS; NANOFIBERS; POLYCAPROLACTONE; PROTEINS; TISSUE;

CARDIAC RECONSTRUCTION; CARDIOMYOCYTES; EXTRACELLULAR MATRICES; MATRIX METALLOPROTEINASES; MATRIX SYNTHESIS; MYOCARDIAL INFARCTION; THREEDIMENSIONAL (3-D); TISSUE-ENGINEERED SCAFFOLDS;

SCAFFOLDS (BIOLOGY);

ALPHA ACTININ; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CYTOKINE; ELASTIN; FIBRILLIN; FIBRONECTIN; GELATINASE A; GELATINASE B; HYALURONIC ACID; LAMININ; MOLECULAR SCAFFOLD; NANOFIBER; POLYCAPROLACTONE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TROPOELASTIN; BIOMIMETIC MATERIAL; COLLAGENASE; HYDROGEL; TISSUE INHIBITOR OF METALLOPROTEINASE-1 PROTEIN, RAT;

ANIMAL CELL; ARTICLE; BIOMIMETICS; CELL ADHESION; CELL SURVIVAL; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; HEART MUSCLE CELL; HYDROGEL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; NONHUMAN; RAT; SCANNING ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMISTRY; CYTOLOGY; METABOLISM; MOUSE; TISSUE SCAFFOLD;

ANIMALS; BIOMIMETIC MATERIALS; CELLS, CULTURED; COLLAGEN; COLLAGENASES; EXTRACELLULAR MATRIX; HYDROGEL; MICE; MYOCYTES, CARDIAC; RATS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE SCAFFOLDS;

EID: 84924532386     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.35217     Document Type: Article

References (70)

1. American Heart Association: Heart disease and stroke statistics-2010 update. Dallas, TX: American Heart Association; 2010.
2. Forte G, Pagliari S, Pagliari F, Ebara M, Di Nardo P, Aoyagi T,. Towards the generation of patient-specific patches for cardiac repair. Stem Cell Rev 2013; 9: 313-325.
3. Germani A, Di Rocco G, Limana F, Martelli F, Capogrossi MC,. Molecular mechanisms of cardiomyocyte regeneration and therapeutic outlook. Trends Mol Med 2007; 13: 125-133.
4. Bergmann O, Bhardwaj RD, Bernard S, Zdunek S, Barnabe-Heider F, Walsh S, Zupicich J, Alkass K, Buchholz BA, Druid H, Jovinge S, Frisen J. Evidence for cardiomyocyte renewal in humans. Science 2009; 324: 98-102.
5. Guan K, Hasenfuss G,. Cardiac resident progenitor cells: Evidence and functional significance. Eur Heart J 2013; 34: 2784-2787.
6. Sharma R, Raghubir R,. Stem cell therapy: A hope for dying hearts. Stem Cells Dev 2007; 16: 517-536.
7. Oh H, Bradfute SB, Gallardo TD, Nakamura T, Gaussin V, Mishina Y, Pocius J, Michael LH, Behringer RR, Garry DJ, Entman ML, Schneider MD. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc Natl Acad Sci USA 2003; 100: 12313-12318.
8. van der Heyden MA, van Veen TA, Sluijter JP, Doevendans PA, Goumans MJ,. Foetal and adult cardiomyocyte progenitor cells have different developmental potential. J Cell Mol Med 2010; 14: 861-870.
9. Gallagher GL, Jackson CJ, Hunyor SN,. Myocardial extracellular matrix remodeling in ischemic heart failure. Front Biosci 2007; 12: 1410-1419.
10. Jourdan-Lesaux C, Zhang J, Lindsey ML,. Extracellular matrix roles during cardiac repair. Life Sci 2010; 87: 391-400.
11. Dobaczewski M, Gonzalez-Quesada C, Frangogiannis NG,. The extracellular matrix as a modulator of the inflammatory and reparative response following myocardial infarction. J Mol Cell Cardiol 2010; 48: 504-511.
12. Cohn JN, Johnson G, Ziesche S, Cobb F, Francis G, Tristani F, Smith R, Dunkman WB, Loeb H, Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991; 325: 303-310.
13. Kass DA, Baughman KL, Pak PH, Cho PW, Levin HR, Gardner TJ, Halperin HR, Tsitlik JE, Acker MA. Reverse remodeling from cardiomyoplasty in human heart failure. External constraint versus active assist. Circulation 1995; 91: 2314-2318.
14. McCarthy PM, Smedira NO, Vargo RL, Goormastic M, Hobbs RE, Starling RC, Young JB. One hundred patients with the HeartMate left ventricular assist device: Evolving concepts and technology. J Thorac Cardiovasc Surg 1998; 115: 904-912.
15. McCarthy PM, Starling RC, Wong J, Scalia GM, Buda T, Vargo RL, Goormastic M, Thomas JD, Smedira NG, Young JB. Early results with partial left ventriculectomy. J Thorac Cardiovasc Surg 1997; 114: 763-765.
16. Orlic D, Kajstura J, Chimenti S, Jakoniuk I, Anderson SM, Li B, Pickel J, McKay R, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410: 221-229.
17. Orlic D, Kajstura J, Chimenti S, Limana F, Jakoniuk I, Quaini F, Nadal-Ginard B, Bodine DM, Leri A, Anversa P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc Natl Acad Sci USA 2001; 98: 10344-10349.
18. Wagers AJ, Sherwood RI, Christensen JL, Weissman IL,. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 2002; 297: 2256-2259.
19. Bearzi C, Rota M, Hosoda T, Tillmanns J, Nascimbene A, De Angelis A, Yasuzawa-Amano S, Trofimova I, Siggins RW, Lecapitaine N, Cascapera S, Beltrami AP, D'Alessandro DA, Zias E, Quaini F, Urbanek K, Michler RE, Bolli R, Kajstura J, Leri A, Anversa P. Human cardiac stem cells. Proc Natl Acad Sci USA 2007; 104: 14068-14073.
20. Nussbaum J, Minami E, Laflamme MA, Virag JA, Ware CB, Masino A, Muskheli V, Pabon L, Reinecke H, Murry CE. Transplantation of undifferentiated murine embryonic stem cells in the heart: Teratoma formation and immune response. FASEB J 2007; 21: 1345-1357.
21. Itzhaki-Alfia A, Leor J, Raanani E, Sternik L, Spiegelstein D, Netser S, Holbova R, Pevsner-Fischer M, Lavee J, Barbash IM. Patient characteristics and cell source determine the number of isolated human cardiac progenitor cells. Circulation 2009; 120: 2559-2566.
22. Murry CE, Soonpaa MH, Reinecke H, Nakajima H, Nakajima HO, Rubart M, Pasumarthi KB, Virag JI, Bartelmez SH, Poppa V, Bradford G, Dowell JD, Williams DA, Field LJ. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004; 428: 664-668.
23. Fujiwara M, Yan P, Otsuji TG, Narazaki G, Uosaki H, Fukushima H, Kuwahara K, Harada M, Matsuda H, Matsuoka S, Okita K, Takahashi K, Nakagawa M, Ikeda T, Sakata R, Mummery CL, Nakatsuji N, Yamanaka S, Nakao K, Yamashita JK. Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A. PLoS One 2011; 6: e16734.
24. Mauritz C, Schwanke K, Reppel M, Neef S, Katsirntaki K, Maier LS, Nguemo F, Menke S, Haustein M, Hescheler J, Hasenfuss G, Martin U. Generation of functional murine cardiac myocytes from induced pluripotent stem cells. Circulation 2008; 118: 507-517.
25. Esteban MA, Wang T, Qin B, Yang J, Qin D, Cai J, Li W, Weng Z, Chen J, Ni S, Chen K, Li Y, Liu X, Xu J, Zhang S, Li F, He W, Labuda K, Song Y, Peterbauer A, Wolbank S, Redl H, Zhong M, Cai D, Zeng L, Pei D. Vitamin C enhances the generation of mouse and human induced pluripotent stem cells. Cell Stem Cell 2010; 6: 71-79.
26. Zhao T, Zhang ZN, Rong Z, Xu Y,. Immunogenicity of induced pluripotent stem cells. Nature 2011; 474: 212-215.
27. Castells-Sala C, Semino CE,. Biomaterials for stem cell culture and seeding for the generation and delivery of cardiac myocytes. Curr Opin Organ Transplant 2012; 17: 681-687.
28. Barsotti MC, Felice F, Balbarini A, Di Stefano R,. Fibrin as a scaffold for cardiac tissue engineering. Biotechnol Appl Biochem 2011; 58: 301-310.
29. Iyer RK, Chiu LL, Reis LA, Radisic M,. Engineered cardiac tissues. Curr Opin Biotechnol 2011; 22: 706-714.
30. Tee R, Lokmic Z, Morrison WA, Dilley RJ,. Strategies in cardiac tissue engineering. ANZ J Surg 2010; 80: 683-693.
31. Zimmermann WH, Melnychenko I, Eschenhagen T,. Engineered heart tissue for regeneration of diseased hearts. Biomaterials 2004; 25: 1639-1647.
32. Zimmermann WH, Eschenhagen T,. Cardiac tissue engineering for replacement therapy. Heart Fail Rev 2003; 8: 259-269.
33. Venugopal JR, Prabhakaran MP, Mukherjee S, Ravichandran R, Dan K, Ramakrishna S,. Biomaterial strategies for alleviation of myocardial infarction. J R Soc Interface 2012; 9: 1-19.
34. Ye Z, Zhou Y, Cai H, Tan W,. Myocardial regeneration: Roles of stem cells and hydrogels. Adv Drug Deliv Rev 2011; 63: 688-697.
35. Sy JC, Davis ME,. Delivering regenerative cues to the heart: Cardiac drug delivery by microspheres and peptide nanofibers. J Cardiovasc Transl Res 2010; 3: 461-468.
36. Shapira K, Dikovsky D, Habib M, Gepstein L, Seliktar D,. Hydrogels for cardiac tissue regeneration. Biomed Mater Eng 2008; 18: 309-314.
37. Kim DH, Lipke EA, Kim P, Cheong R, Thompson S, Delannoy M, Suh KY, Tung L, Levchenko A. Nanoscale cues regulate the structure and function of macroscopic cardiac tissue constructs. Proc Natl Acad Sci USA 2010; 107: 565-570.
38. Radisic M, Park H, Shing H, Consi T, Schoen FJ, Langer R, Freed LE, Vunjak-Novakovic G. Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci USA 2004; 101: 18129-18134.
39. Bursac N, Papadaki M, White JA, Eisenberg SR, Vunjak-Novakovic G, Freed LE,. Cultivation in rotating bioreactors promotes maintenance of cardiac myocyte electrophysiology and molecular properties. Tissue Eng 2003; 9: 1243-1253.
40. Kumbar SG, James R, Nukavarapu SP, Laurencin CT,. Electrospun nanofiber scaffolds: Engineering soft tissues. Biomed Mater 2008; 3: 034002.
41. Oh B, Lee CH,. Nanofiber for cardiovascular tissue engineering. Expert Opin Drug Deliv 2013; 10: 1565-1582.
42. Dahlin RL, Kasper FK, Mikos AG,. Polymeric nanofibers in tissue engineering. Tissue Eng Part B Rev 2011; 17: 349-364.
43. Stout DA, Basu B, Webster TJ,. Poly(lactic-co-glycolic acid): Carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater 2011; 7: 3101-112.
44. Dvir T, Timko BP, Brigham MD, Naik SR, Karajanagi SS, Levy O, Jin H, Parker KK, Langer R, Kohane DS. Nanowired three-dimensional cardiac patches. Nat Nanotechnol 2011; 6: 720-725.
45. Stout DA BB, Webster TJ,. Poly(lactic-co-glycolic acid): Carbon nanofiber composites for myocardial tissue engineering applications. Acta Biomater 2011; 7: 3101-3112.
46. Gupta V, Grande-Allen KJ,. Effects of static and cyclic loading in regulating extracellular matrix synthesis by cardiovascular cells. Cardiovasc Res 2006; 72: 375-383.
47. Castaldo C, Di Meglio F, Miraglia R, Sacco AM, Romano V, Bancone C, Della Corte A, Montagnani S, Nurzynska D. Cardiac fibroblast-derived extracellular matrix (biomatrix) as a model for the studies of cardiac primitive cell biological properties in normal and pathological adult human heart. Biomed Res Int 2013; 2013: 352370.
48. Callegari A, Bollini S, Iop L, Chiavegato A, Torregrossa G, Pozzobon M, Gerosa G, De Coppi P, Elvassore N, Sartore S. Neovascularization induced by porous collagen scaffold implanted on intact and cryoinjured rat hearts. Biomaterials 2007; 28: 5449-5461.
49. Zimmermann WH, Fink C, Kralisch D, Remmers U, Weil J,. Three-dimensional engineered heart tissue from neonatal rat cardiac myocytes. Biotechnol Bioeng 2000; 68: 106-114.
50. Radisic M, Euloth M, Yang L, Langer R, Freed LE, Vunjak-Novakovic G,. High-density seeding of myocyte cells for cardiac tissue engineering. Biotechnol Bioeng 2003; 82: 403-414.
51. Yamamura N, Sudo R, Ikeda M, Tanishita K,. Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells. Tissue Eng 2007; 13: 1443-1453.
52. Yang YL, Leone LM, Kaufman LJ,. Elastic moduli of collagen gels can be predicted from two-dimensional confocal microscopy. Biophys J 2009; 97: 2051-2060.
53. Xie J, MacEwan MR, Li X, Sakiyama-Elbert SE, Xia Y,. Neurite outgrowth on nanofiber scaffolds with different orders, structures, and surface properties. ACS Nano 2009; 3: 1151-1159.
54. Patel S, Kurpinski K, Quigley R, Gao H, Hsiao BS, Poo MM, Li S. Bioactive nanofibers: Synergistic effects of nanotopography and chemical signaling on cell guidance. Nano Lett 2007; 7: 2122-2128.
55. Kothapalli CR, Taylor PM, Smolenski RT, Yacoub MH, Ramamurthi A,. Transforming growth factor beta 1 and hyaluronan oligomers synergistically enhance elastin matrix regeneration by vascular smooth muscle cells. Tissue Eng Part A 2009; 15: 501-511.
56. Pok S, Myers JD, Madihally SV, Jacot JG,. A multilayered scaffold of a chitosan and gelatin hydrogel supported by a PCL core for cardiac tissue engineering. Acta Biomater 2013; 9: 5630-5642.
57. Willits RK, Skornia SL., Effect of collagen gel stiffness on neurite extension. J Biomater Sci Polym Ed 2004; 15: 1521-1531.
58. Evans HJ, Sweet JK, Price RL, Yost M, Goodwin RL,. Novel 3D culture system for study of cardiac myocyte development. Am J Physiol Heart Circ Physiol 2003; 285: H570-H578.
59. Ikonen L, Kerkela E, Kujala K, Haaparantam A-M, Ahola N, Ella V, Poh TL, Kellomaki M, Aalto-Setala K. Analysis of different natural and synthetic biomaterials to support cardiomyocyte growth. J Clinic Experiment Cardiol 2011;S: 4.
60. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA,. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nat Med 2002; 8: 850-855.
61. Hellman U, Malm L, Ma LP, Larsson G, Mörner S, Fu M, Engström-Laurent A, Waldenström A. Growth factor PDGF-BB stimulates cultured cardiomyocytes to synthesize the extracellular matrix component hyaluronan. PLoS One 2010; 5: e14393.
62. Mizuno T, Mickle DA, Kiani CG, Li RK,. Overexpression of elastin fragments in infarcted myocardium attenuates scar expansion and heart dysfunction. Am J Physiol Heart Circ Physiol 2005; 288: H2819-H2827.
63. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, Goldberg AT, Zellner JL, Crumbley AJ. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation 2000; 102: 1944-1949.
64. Nagase H,. Activation mechanisms of matrix metalloproteinases. Biol Chem 1997; 378: 151-160.
65. Kai D, Prabhakaran MP, Jin G, Ramakrishna S,. Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering. J Biomed Mater Res B Appl Biomater 2011; 98: 379-386.
66. Kuhn LT, Jacobs E, Goldberg AJ,. Evaluation of bio-inspired materials for mineralized tissue regeneration using typeI collagen reporter cells. Hoboken, NJ: Wiley; 2014.
67. Lavagnino M, Arnoczky SP, Frank K, Tian T,. Collagen fibril diameter distribution does not reflect changes in the mechanical properties of in vitro stress-deprived tendons. J Biomech 2005; 38: 69-75.
68. Shapira-Schweitzer K, Seliktar D,. Matrix stiffness affects spontaneous contraction of cardiomyocytes cultured within a PEGylated fibrinogen biomaterial. Acta Biomater 2007; 3: 33-41.
69. Bird SD, Doevendans PA, van Rooijen MA, Brutel de la Riviere A, Hassink RJ, Passier R, Mummery CL. The human adult cardiomyocyte phenotype. Cardiovasc Res 2003; 58: 423-434.
70. Hussain A, Collins G, Yip D, Cho CH,. Functional 3-D cardiac co-culture model using bioactive chitosan nanofiber scaffolds. Biotechnol Bioeng 2013; 110: 637-647.